company background image

National ResearchNasdaqGS:NRC Stock Report

Market Cap







26 Sep, 2021


Company Financials
NRC fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance3/6
Financial Health5/6

NRC Overview

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.

Price History & Performance

Summary of all time highs, changes and price drops for National Research
Historical stock prices
Current Share PriceUS$45.16
52 Week HighUS$42.41
52 Week LowUS$59.20
1 Month Change-17.14%
3 Month Change-3.79%
1 Year Change-3.81%
3 Year Change16.99%
5 Year Change177.23%
Change since IPO125.80%

Recent News & Updates

Shareholder Returns

NRCUS HealthcareUS Market

Return vs Industry: NRC underperformed the US Healthcare industry which returned 33.6% over the past year.

Return vs Market: NRC underperformed the US Market which returned 35.3% over the past year.

Price Volatility

Is NRC's price volatile compared to industry and market?
NRC volatility
NRC Beta0.64
Industry Beta0.87
Market Beta1

Stable Share Price: NRC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: NRC's weekly volatility (3%) has been stable over the past year.

About the Company

1981485Mike Hays

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

National Research Fundamentals Summary

How do National Research's earnings and revenue compare to its market cap?
NRC fundamental statistics
Market CapUS$1.15b
Earnings (TTM)US$35.94m
Revenue (TTM)US$140.14m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NRC income statement (TTM)
Cost of RevenueUS$49.48m
Gross ProfitUS$90.66m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date


Earnings per share (EPS)1.41
Gross Margin64.69%
Net Profit Margin25.64%
Debt/Equity Ratio37.5%

How did NRC perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio

Does NRC pay a reliable dividends?

See NRC dividend history and benchmarks
When do you need to buy NRC by to receive an upcoming dividend?
National Research dividend dates
Ex Dividend DateSep 29 2021
Dividend Pay DateOct 15 2021
Days until Ex dividend2 days
Days until Dividend pay date18 days

Does NRC pay a reliable dividends?

See NRC dividend history and benchmarks


Is National Research undervalued compared to its fair value and its price relative to the market?


Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: NRC ($45.16) is trading below our estimate of fair value ($68.31)

Significantly Below Fair Value: NRC is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: NRC is poor value based on its PE Ratio (32x) compared to the US Healthcare industry average (21.9x).

PE vs Market: NRC is poor value based on its PE Ratio (32x) compared to the US market (17.9x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NRC's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: NRC is overvalued based on its PB Ratio (15x) compared to the US Healthcare industry average (3.2x).

Future Growth

How is National Research forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as National Research has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has National Research performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NRC has high quality earnings.

Growing Profit Margin: NRC's current net profit margins (25.6%) are lower than last year (27.8%).

Past Earnings Growth Analysis

Earnings Trend: NRC's earnings have grown by 13.8% per year over the past 5 years.

Accelerating Growth: NRC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NRC had negative earnings growth (-0.7%) over the past year, making it difficult to compare to the Healthcare industry average (32.2%).

Return on Equity

High ROE: NRC's Return on Equity (47.1%) is considered outstanding.

Financial Health

How is National Research's financial position?

Financial Position Analysis

Short Term Liabilities: NRC's short term assets ($67.6M) exceed its short term liabilities ($40.0M).

Long Term Liabilities: NRC's short term assets ($67.6M) exceed its long term liabilities ($35.5M).

Debt to Equity History and Analysis

Debt Level: NRC's debt to equity ratio (37.5%) is considered satisfactory.

Reducing Debt: NRC's debt to equity ratio has increased from 5.3% to 37.5% over the past 5 years.

Debt Coverage: NRC's debt is well covered by operating cash flow (182.9%).

Interest Coverage: NRC's interest payments on its debt are well covered by EBIT (27x coverage).

Balance Sheet


What is National Research current dividend yield, its reliability and sustainability?


Current Dividend Yield

Upcoming Dividend Payment

TodaySep 27 2021Ex Dividend DateSep 29 2021Dividend Pay DateOct 15 202116 days from Ex DividendBuy in the next 2 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: NRC's dividend (1.06%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).

High Dividend: NRC's dividend (1.06%) is low compared to the top 25% of dividend payers in the US market (3.6%).

Stability and Growth of Payments

Stable Dividend: NRC has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: NRC has only been paying a dividend for 7 years, and since then payments have fallen.

Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (16.9%), NRC's dividend payments are well covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Mike Hays (66 yo)





Mr. Michael D. Hays, also known as Mike, serves as an Advisor of Picker Institute Inc. Mr. Hays founded National Research Corp. in 1981 and has been its Chief Executive Officer since 1981 and has been its...

CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD254.50K) is below average for companies of similar size in the US market ($USD2.30M).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: NRC's management team is seasoned and experienced (7.7 years average tenure).

Board Members

Experienced Board: NRC's board of directors are considered experienced (7.6 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: NRC insiders have only sold shares in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

National Research Corporation's employee growth, exchange listings and data sources

Key Information

  • Name: National Research Corporation
  • Ticker: NRC
  • Exchange: NasdaqGS
  • Founded: 1981
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$1.148b
  • Shares outstanding: 25.43m
  • Website:

Number of Employees


  • National Research Corporation
  • 1245 Q Street
  • Lincoln
  • Nebraska
  • 68508
  • United States


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/26 22:15
End of Day Share Price2021/09/24 00:00
Annual Earnings2020/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.